Leptospirosis Prophylaxis Dosing Frequency
For pre-exposure prophylaxis, doxycycline 200 mg should be given once weekly during the period of exposure risk, with post-exposure prophylaxis given as a single 200 mg dose after exposure.
Pre-Exposure Prophylaxis
The standard regimen for individuals with anticipated ongoing exposure (such as military personnel, agricultural workers, or residents in endemic areas during high-risk seasons) is:
- Doxycycline 200 mg orally once weekly throughout the exposure period 1
- Continue weekly dosing for the duration of risk exposure
- Can be discontinued 48 hours after the last perceived exposure (extrapolating from plague prophylaxis guidance, as leptospirosis-specific guidelines are limited)
The landmark 1984 trial in U.S. soldiers training in Panama demonstrated 95% efficacy with weekly doxycycline 200 mg, with only 1 case in the doxycycline group versus 20 cases in placebo (attack rate 0.2% vs 4.2%, P<0.001) 1. This weekly dosing regimen has become the standard approach for pre-exposure prophylaxis.
Post-Exposure Prophylaxis
For individuals with recent high-risk exposure (particularly those with laceration wounds exposed to contaminated water):
- Single dose of doxycycline 200 mg administered as soon as possible after exposure 2
- This single-dose approach showed 76.8% protective efficacy overall and 92% efficacy in those with laceration wounds 2
Important Clinical Considerations
Adverse effects are common with weekly doxycycline: Nausea and vomiting occur significantly more frequently (OR 11,95% CI 2.1-60) 3. Counsel patients about gastrointestinal side effects and consider taking with food.
Efficacy limitations: While doxycycline prophylaxis significantly reduces clinical disease (3.11% vs 6.82% attack rates), it may not completely prevent leptospiral infection/seroconversion 4. The primary benefit is reducing morbidity and mortality rather than preventing all infections.
Target populations for prophylaxis:
- Military personnel or travelers with short-term high-risk exposure in endemic areas
- Residents in endemic areas during outbreak periods (typically 3-week seasonal outbreaks)
- Individuals with laceration wounds and flood water exposure
- Those with >3 hours daily exposure to contaminated water
Evidence Quality Note
The 2024 Cochrane review found very low to low certainty evidence for leptospirosis prophylaxis 5, with only three trials evaluating doxycycline and significant methodological limitations. However, the 1984 military trial 1 remains the highest quality evidence supporting weekly dosing, and the 2014 Thai flood study 2 provides the best evidence for single-dose post-exposure prophylaxis in high-risk scenarios.
Do not use continuous daily dosing - there is no evidence supporting this approach, and it would unnecessarily increase adverse effects and antibiotic resistance concerns.